sub:provenance {
sub:assertion prov:generatedAtTime "2021-12-16T19:43:14.148662"^^
xsd:dateTime ;
prov:wasGeneratedBy "S&T TWOC project version 2" .
sub:version prov:value 2 .
rdf:OBJECT rdfs:label "the risk of any severe AEs by 52 % ( 0.48 , 0.34–0.67 ) , 24 % ( 0.77 , 0.63–0.92 ) , 40 % ( 0.60 , 0.37–0.98 ) , and 50 % ( 0.50 , 0.25–0.98 ) respectively" .
rdf:OBJECT-POSITION rdfs:label 15 .
rdf:PREDICATE rdfs:label "reduced" .
rdf:PREDICATE-POSITION rdfs:label "[101]" .
rdf:SUBJECT rdfs:label "remdesivir for both 5 and 10 days , lopinavir / ritonavir , and dexamethasone" .
rdf:SUBJECT-POSITION rdfs:label 63 .
rdfs:ABSTRACT-UID ns3:50 "8snyy5zp" .
rdfs:SENTENCE rdfs:label "Compared to standard care, remdesivir for both 5 and 10 days, lopinavir/ritonavir, and dexamethasone reduced the risk of any severe AEs by 52% (0.48, 0.34–0.67), 24% (0.77, 0.63–0.92), 40% (0.60, 0.37–0.98), and 50% (0.50, 0.25–0.98) respectively." .
rdfs:TRIPLE-UID ns2:8snyy5zp-TRIPLE-ABSTRACT-1 "8snyy5zp-TRIPLE-ABSTRACT-1" .
<
https://uts.nlm.nih.gov/uts/umls/concept/C0011777>
rdfs:label "dexamethasone" .
<
https://uts.nlm.nih.gov/uts/umls/concept/C0205082>
rdfs:label "severe" .
}